PolyPid Announces Eligibility for European Medicines Agency Centralized Procedure for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
Centralized Procedure Allows for Submission of a Single Marketing Application to the European Medicines Agency that, if Approved, Would Allow D-PLEX100 to be Marketed in All EU Member States ... | September 28, 2022
Dikla Czaczkes Akselbrad Bob Yedid Company Annual Report On Form Exchange Commission European Union European Medicines Agency
Source: marketscreener.com